Displaying 1 - 12 of 34
Metabolism, Alcohol & Toxicity

Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the MASH Paradigm With THR-β Agonists and Other Disease-Specific Therapies

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration (Comp...

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and a journey back to 1992

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Personal perspectives: What is the most significant advance in the last 10 years?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?

Webcasts
View
Displaying 1 - 12 of 34